Company: RGNT
Filing Date: 2025-03-11
Form Type: F-1
Source: 0001213900-25-022350
Chunk: 33

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-03-11
Form: F-1
Chunk 33
---
 make any necessary debt or equity financing
more difficult, more costly, more onerous with respect to financial and operating covenants and more dilutive. Failure to secure any
necessary financing in a timely manner and on favorable terms could have a material adverse effect on our growth strategy, financial
performance and stock price and could require us to alter our operating plans. In addition, there is a risk that one or more of our service
providers, financial institutions, manufacturers, suppliers and other partners may be adversely affected by the foregoing risks, which
could directly affect our ability to attain our operating goals on schedule and on budget.

<div align='center'>23</div>

We are highly dependent on key members of our executive management team. Our inability to retain these individuals could impede our business plan and growth strategies, which could have a negative impact on our business and the value of your investment.

Our ability to implement
our business plan depends on the continued services of key members of our senior management. In particular, and to a critical extent,
we are dependent on the continued efforts and services of the members of management named in the “Management”. If we lose
the services of such key members of our management team, we would likely be forced to expend significant time and money in the pursuit
of replacement individuals, which may result in a delay in the implementation of our business plan and plan of operations. We may not
be able to find satisfactory replacements on terms that would not be unduly expensive or burdensome to us. We do not currently carry
a key-man life insurance policy that would assist us in recouping our costs in the event of the death or disability of our management
team. The loss of members of our management team, or our inability to attract or retain other qualified individuals, could have a material
adverse effect on our business, results of operations and financial condition.

Exchange rate fluctuations between the U.S. dollar and the New Israeli Shekel and inflation may negatively affect our results of operations, and we may not be able to hedge our currency exchange risks successfully.

The U.S. dollar is our functional
and reporting currency. However, a portion of our operating expenses, including personnel and facilities related expenses, are incurred
in NIS. As a result, we are exposed to the risks that the NIS may appreciate relative to the U.S. dollar, or, if the NIS instead devalues
relative to the U.S. dollar, that the inflation rate in Israel may exceed such rate of de